Recombinant Human PD-L1/B7-H1 Protein

This protein is an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation.

Proteins

Phe19-Thr239

Immune Checkpoint, Bio-Markers & CD Antigens, Biosimilar Drug Targets

Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation.

1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human PD-L1 at 10 μg/mL (100 μL/well) can bind Recombinant Human PD-1 with a linear range of 0.25-1.02 μg/mL.|2.Measured by its binding ability in a functional ELISA.Immobilized PE anti-human CD274 (B7-H1, PD-L1) Antibody at 1μg/mL (25 μL/well) can bind Human CD274 with a linear range of 0.46-18ng/mL.